The Paradox of Triple Negative Breast Cancer: Novel Approaches to Treatment von Fornier, Monica, Fumoleau, Pierre

Volltext

Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Th... von BASELGA, José, GELMON, Karen A, FUMOLEAU, Pierre, GIANNI, Luca, VERMA, Shailendra, WARDLEY, Andrew, CONTE, Pierfranco, MILES, David, BIANCHI, Giulia, CORTES, Javier, MCNALLY, Virginia A, ROSS, Graham A

Volltext

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial von Pivot, Xavier, Prof, Romieu, Gilles, MD, Debled, Marc, MD, Pierga, Jean-Yves, Prof, Kerbrat, Pierre, Prof, Bachelot, Thomas, MD, Lortholary, Alain, MD, Espié, Marc, MD, Fumoleau, Pierre, Prof, Serin, Daniel, MD, Jacquin, Jean-Philippe, MD, Jouannaud, Christelle, MD, Rios, Maria, MD, Abadie-Lacourtoisie, Sophie, MD, Tubiana-Mathieu, Nicole, Prof, Cany, Laurent, MD, Catala, Stéphanie, MD, Khayat, David, Prof, Pauporté, Iris, PhD, Kramar, Andrew, PhD

Volltext

Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast... von WOLFF, Antonio C, LAZAR, Ann A, CHAN, Arlene, HACHEMI, Soulef, STRAHS, Andrew, CINCOTTA, Maria, BERKENBLIT, Anna, KRYGOWSKI, Mizue, KANG, Lih Lisa, MOORE, Laurence, HAYES, Daniel F, BONDARENKO, Igor, GARIN, August M, BRINCAT, Stephen, CHOW, Louis, YAN SUN, NESKOVIC-KONSTANTINOVIC, Zora, GUIMARAES, Rodrigo C, FUMOLEAU, Pierre

Volltext

Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells von LADOIRE, Sylvain, ARNOULD, Laurent, APETOH, Lionel, COUDERT, Bruno, MARTIN, Francois, CHAUFFERT, Bruno, FUMOLEAU, Pierre, GHIRINGHELLI, Francois

Volltext

Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Fa... von CORTES, Javier, FUMOLEAU, Pierre, SALVAGNI, Stefania, SERVENT, Veronique, GIANNI, Luca, SCALTRITI, Maurizio, ROSS, Graham A, DIXON, Joanna, SZADO, Tania, BASELGA, José, VALERIA BIANCHI, Giulia, PETRELLA, Teresa M, GELMON, Karen, PIVOT, Xavier, VERMA, Shailendra, ALBANELL, Joan, CONTE, Pierfranco, LLUCH, Ana

Volltext

In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival von Ladoire, Sylvain, Mignot, Grégoire, Dabakuyo, Sandrine, Arnould, Laurent, Apetoh, Lionel, Rébé, Cedric, Coudert, Bruno, Martin, Francois, Bizollon, Marie Hélène, Vanoli, André, Coutant, Charles, Fumoleau, Pierre, Bonnetain, Franck, Ghiringhelli, François

Volltext

Exosomes in cancer theranostic: Diamonds in the rough von Cordonnier, Marine, Chanteloup, Gaëtan, Isambert, Nicolas, Seigneuric, Renaud, Fumoleau, Pierre, Garrido, Carmen, Gobbo, Jessica

Volltext

Identification of molecular apocrine breast tumours by microarray analysis von Farmer, Pierre, Bonnefoi, Herve, Becette, Veronique, Tubiana-Hulin, Michele, Fumoleau, Pierre, Larsimont, Denis, MacGrogan, Gaetan, Bergh, Jonas, Cameron, David, Goldstein, Darlene, Duss, Stephan, Nicoulaz, Anne-Laure, Brisken, Cathrin, Fiche, Maryse, Delorenzi, Mauro, Iggo, Richard

Volltext

Multicenter Phase III Randomized Trial Comparing Docetaxel and Trastuzumab With Docetaxel, Carboplatin, and Trastuzumab As First-Line Chemotherapy for Patients With HER2-Gene-Ampli... von VALERO, Vicente, FORBES, John, FUMOLEAU, Pierre, ROLSKI, Janusz, MRSIC-KRMPOTIC, Zrinka, JAGIELLO-GRUSZFELD, Agnieszka, RIVA, Alessandro, BUYSE, Marc, TAUPIN, Henry, SAUTER, Guido, PRESS, Michael F, SLAMON, Dennis J, PEGRAM, Mark D, PIENKOWSKI, Tadeusz, EIERMANN, Wolfgang, VON MINCKWITZ, Gunter, ROCHE, Henri, MARTIN, Miguel, CROWN, John, MACKEY, John R

Volltext

Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer von Ladoire, Sylvain, Penault-Llorca, Frédérique, Senovilla, Laura, Dalban, Cécile, Enot, David, Locher, Clara, Prada, Nicole, Poirier-Colame, Vichnou, Chaba, Kariman, Arnould, Laurent, Ghiringhelli, François, Fumoleau, Pierre, Spielmann, Marc, Delaloge, Suzette, Poillot, Marie Laure, Arveux, Patrick, Goubar, Aicha, Andre, Fabrice, Zitvogel, Laurence, Kroemer, Guido

Volltext

Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 Trial von ROCHE, Henri, FUMOLEAU, Pierre, VIENS, Patrice, MONNIER, Alain, VINDEVOGHEL, Anita, CAMPONE, Mario, GOUDIER, Marie-Josèphe, BONNETERRE, Jacques, FERRERO, Jean-Marc, MARTIN, Anne-Laure, GENEVE, Jean, ASSELAIN, Bernard, SPIELMANN, Marc, CANON, Jean-Luc, DELOZIER, Thierry, SERIN, Daniel, SYMANN, Michel, KERBRAT, Pierre, SOULIE, Patrick, EICHLER, Francoise

Volltext

Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial Results von O'SHAUGHNESSY, Joyce, MILES, David, TWELVES, Chris, VAN HAZEL, Guy, VERMA, Shailendra, LEONARD, Robert, VUKELJA, Svetislava, MOISEYENKO, Vladimir, AYOUB, Jean-Pierre, CERVANTES, Guadalupe, FUMOLEAU, Pierre, JONES, Stephen, LUI, Wing-Yiu, MAURIAC, Louis

Volltext

Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial von Goss, Paul E, Prof, Smith, Ian E, Prof, O'Shaughnessy, Joyce, MD, Ejlertsen, Bent, Prof, Kaufmann, Manfred, Prof, Boyle, Frances, MBBS, Buzdar, Aman U, Prof, Fumoleau, Pierre, Prof, Gradishar, William, Prof, Martin, Miguel, Prof, Moy, Beverly, MD, Piccart-Gebhart, Martine, MD, Pritchard, Kathleen I, Prof, Lindquist, Deborah, MD, Chavarri-Guerra, Yanin, MD, Aktan, Gursel, MD, Rappold, Erica, BSN, Williams, Lisa S, MSc, Finkelstein, Dianne M, Prof

Volltext

Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Patients With Taxane-Resistant Metastatic Breast Cancer von THOMAS, Eva, TABERNERO, Josep, BASELGA, José, RIVERA, Edgardo, GUARNERI, Valentina, POULART, Valerie, KLIMOVSKY, Judith, LEBWOHL, David, MARTIN, Miguel, FORNIER, Monica, CONTE, Pierfranco, FUMOLEAU, Pierre, LLUCH, Ana, VAHDAT, Linda T, BUNNELL, Craig A, BURNS, Howard A, VIENS, Patrice

Volltext

Phase II Study of Imatinib in Patients With Recurrent Gliomas of Various Histologies: A European Organisation for Research and Treatment of Cancer Brain Tumor Group Study von RAYMOND, Eric, BRANDES, Alba A, HEINRICH, Michael C, GORLIA, Thierry, LACOMBE, Denis, VAN DEN BENT, Martin J, DITTRICH, Christian, FUMOLEAU, Pierre, COUDERT, Bruno, CLEMENT, Paul M. J, FRENAY, Marc, RAMPLING, Roy, STUPP, Roger, KROS, Johan M

Volltext

FDG PET/CT for prognostic stratification of patients with metastatic breast cancer treated with first line systemic therapy: Comparison of EORTC criteria and PERCIST von Depardon, Edouard, Kanoun, Salim, Humbert, Olivier, Bertaut, Aurélie, Riedinger, Jean-Marc, Tal, Ilan, Vrigneaud, Jean-Marc, Lasserre, Maud, Toubeau, Michel, Berriolo-Riedinger, Alina, Dygai-Cochet, Inna, Fumoleau, Pierre, Brunotte, François, Cochet, Alexandre

Volltext

TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial von Bonnefoi, Hervé, Prof, Piccart, Martine, Prof, Bogaerts, Jan, PhD, Mauriac, Louis, MD, Fumoleau, Pierre, Prof, Brain, Etienne, MD, Petit, Thierry, Prof, Rouanet, Philippe, Prof, Jassem, Jacek, Prof, Blot, Emmanuel, MD, Zaman, Khalil, MD, Cufer, Tanja, Prof, Lortholary, Alain, MD, Lidbrink, Elisabet, MD, André, Sylvie, Litière, Saskia, PhD, Lago, Lissandra Dal, MD, Becette, Véronique, MD, Cameron, David A, Prof, Bergh, Jonas, Prof, Iggo, Richard, Prof

Volltext

Next-generation sequencing analysis of lung and colon carcinomas reveals a variety of genetic alterations von CHEVRIER, SANDY, ARNOULD, LAURENT, GHIRINGHELLI, FRANÇOIS, COUDERT, BRUNO, FUMOLEAU, PIERRE, BOIDOT, ROMAIN

Volltext

The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubici... von Penault-Llorca, Frédérique, Filleron, Thomas, Asselain, Bernard, Baehner, Frederick L, Fumoleau, Pierre, Lacroix-Triki, Magali, Anderson, Joseph M, Yoshizawa, Carl, Cherbavaz, Diana B, Shak, Steven, Roca, Lise, Sagan, Christine, Lemonnier, Jérôme, Martin, Anne-Laure, Roché, Henri

Volltext